Rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism in African American patients: a retrospective cohort analysis

被引：0
|
作者：
Olivia S. Costa
Stanley Thompson
Veronica Ashton
Michael Palladino
Thomas J. Bunz
Craig I. Coleman
机构：
[1] University of Connecticut School of Pharmacy,Department of Pharmacy Practice
[2] Hartford Hospital,Evidence
[3] TeamHealth LifePoint Group,Based Practice Center
[4] Janssen Scientific Affairs LLC,Real World Value and Evidence
[5] Medical Affairs,Department of Pharmacoepidemiology
[6] Janssen Pharmaceuticals Inc.,undefined
[7] New England Health Analytics LLC,undefined
来源：
Thrombosis Journal | / 18卷
关键词：
African Americans; Anticoagulants; Rivaroxaban; Venous thromboembolism; Warfarin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism in African American patients: a retrospective cohort analysis
    Costa, Olivia S.
    Thompson, Stanley
    Ashton, Veronica
    Palladino, Michael
    Bunz, Thomas J.
    Coleman, Craig, I
    [J]. THROMBOSIS JOURNAL, 2020, 18 (01)
  • [2] RIVAROXABAN VERSUS WARFARIN FOR TREATMENT AND PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM IN AFRICAN AMERICAN PATIENTS
    Costa, Olivia S.
    Thompson, Stanley
    Ashton, Veronica
    Palladino, Michael
    Bunz, Thomas J.
    Coleman, Craig I.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S261 - S261
  • [3] Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism
    Coleman, Craig I.
    Bunz, Thomas J.
    Turpie, Alexander G. G.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2017, 117 (10) : 1841 - 1847
  • [4] APIXABAN AND RIVAROXABAN VERSUS WARFARIN FOR TREATMENT OF VENOUS THROMBOEMBOLISM IN OBESE PATIENTS
    Kafka, Wesley
    Cook, Stephen
    Ferris, Jessica
    Hill, Sharon
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [5] Rivaroxaban Versus Warfarin for Management of Obese African Americans With Non-Valvular Atrial Fibrillation or Venous Thromboembolism: A Retrospective Cohort Analysis
    Costa, Olivia S.
    Beyer-Westendorf, Jan
    Ashton, Veronica
    Milentijevic, Dejan
    Moore, Kenneth Todd
    Bunz, Thomas J.
    Coleman, Craig I.
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2020, 26
  • [6] Rivaroxaban vs. warfarin for the treatment and prevention of venous thromboembolism: A meta-analysis
    Liu, Zhuang
    Song, Dan
    Wang, Liang
    Wang, Changfeng
    Zhou, Jie
    Sun, Jiali
    Guo, Lei
    [J]. FRONTIERS IN SURGERY, 2023, 10
  • [7] EFFECTIVENESS AND SAFETY OF RIVAROXABAN VERSUS WARFARIN IN PATIENTS WITH UNPROVOKED VENOUS THROMBOEMBOLISM
    Coleman, Craig I.
    Bunz, Thomas J.
    Peacock, W. Frank
    Martinez, Brandon K.
    Baker, William L.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E12 - E12
  • [8] Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism
    Coleman, Craig I.
    Turpie, Alexander G. G.
    Bunz, Thomas J.
    Beyer-Westendorf, Jan
    [J]. AMERICAN JOURNAL OF MEDICINE, 2018, 131 (08): : 933 - +
  • [9] Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis
    Dawwas, Ghadeer K.
    Brown, Joshua
    Dietrich, Eric
    Park, Haesuk
    [J]. LANCET HAEMATOLOGY, 2019, 6 (01): : E20 - E28
  • [10] Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism
    Craig I. Coleman
    Alexander G. G. Turpie
    Thomas J. Bunz
    Jan Beyer-Westendorf
    [J]. Journal of Thrombosis and Thrombolysis, 2018, 46 : 339 - 345
12345